GAITHERSBURG, Md., Oct. 02, 2023 (GLOBE NEWSWIRE) Emergent BioSolutions Inc. (NYSE:EBS) today announced the appointment of Neal Fowler and Don DeGolyer to its Board of Directors effective October 1, 2023, with
GAITHERSBURG, Md., Oct. 02, 2023 Emergent BioSolutions Inc. today announced the appointment of Neal Fowler and Don DeGolyer to its Board of Directors effective October 1, 2023, with initial.
Jon Kleen, MD, PhD, UC San Francisco neurologist, epileptologist and neuroscientist, has been named the 2023 Dreifuss-Penry Epilepsy Award recipient by the American Academy of Neurology (AAN). He is being honored for his outstanding contributions in
Pathalys Pharma, a newly formed RTP biopharmaceutical company developing therapies for chronic kidney disease, has announced its executive leadership team, led by pharma veteran Neal Fowler.